Paperman Media ( New Delhi )- The 9th edition of India Pharma 2026, organised by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India, in association with FICCI and IPA, New Delhi, successfully concluded today, after two days of extensive deliberations aimed at strengthening India’s pharmaceutical and biopharma ecosystem.
On the second day of the event, two plenary sessions and a valedictory session were held, focusing on strengthening the pharmaceutical financing ecosystem and charting forward-looking pathways for innovation-led growth. The discussions brought together key stakeholders from industry, finance, academia and policy, highlighting the importance of strategic investments, infrastructure and speed in driving the next phase of sectoral transformation. The sessions emphasised a shift from scale to breakthrough innovation, with a strong focus on advanced therapeutics and unlocking new growth frontiers through investment and innovation synergy.
The event witnessed participation from over 800 delegates across both days, with more than 60 speakers engaging in 10 sessions including 6 plenary sessions, supported by over 20 partner organisations.
Delivering the valedictory address, Shri. Satyaprakash T L, Joint Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers noted that discussions across sessions converged around three critical enablers for the next phase of growth: funding, infrastructure and speed. While stakeholders expressed varied views on prioritisation, there was a shared understanding that coordinated action across government, industry and academia is essential. Emphasising the urgency of collaboration, he stated that India must proactively position itself in the evolving global pharmaceutical landscape to remain competitive.
